Literature DB >> 22182456

Sustaining full recovery in schizophrenia after 15 years: does resilience matter?

Anne-Kari Torgalsbøen1.   

Abstract

The main purpose of this study was to follow up a group of persons who, fifteen years ago were considered to be fully recovered from schizophrenia, in order to examine how many have sustained their recovery and to investigate the role of resilience in recovery. A semi-structured interview was designed for this 15-year follow-up study based on previous research related to the course and prognosis of schizophrenia. In addition to the interview, measures of psychosocial functioning and the degree of positive and negative symptoms were used. Remission and recovery were evaluated by consensus-based criteria. The Connor-Davidson Resilience Scale was chosen to assess resilience. The results show a significant correlation between resilience and present psychosocial functioning. There is also a significant difference between fully recovered subjects and those in remission regarding their resilience score. These results show that the majority of the subjects had maintained their recovery, and that subjects who are still fully recovered have not used medication for seventeen years and are more resilient. Thus, a sustained, full recovery without medication seems possible for a subgroup of schizophrenia patients characterized by high resilience.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22182456     DOI: 10.3371/CSRP.5.4.3

Source DB:  PubMed          Journal:  Clin Schizophr Relat Psychoses        ISSN: 1935-1232


  13 in total

1.  Resilience in individuals at clinical high risk for psychosis.

Authors:  Susana Marulanda; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2014-09-18       Impact factor: 2.732

2.  The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Authors:  Silvana Galderisi; Alessandro Rossi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Bucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Antonello Bellomo; Massimo Biondi; Roberto Brugnoli; Liliana Dell'Osso; Diana De Ronchi; Gabriella Di Emidio; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Federica Pinna; Rita Roncone; Emilio Sacchetti; Paolo Santonastaso; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: a waitlist-controlled trial.

Authors:  Nicole R DeTore; Lauren Luther; Wisteria Deng; Jordan Zimmerman; Logan Leathem; Anne S Burke; Maren B Nyer; Daphne J Holt
Journal:  Psychol Med       Date:  2022-03-01       Impact factor: 10.592

Review 4.  Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Authors:  Nancy Sohler; Ben G Adams; David M Barnes; Gregory H Cohen; Seth J Prins; Sharon Schwartz
Journal:  Am J Orthopsychiatry       Date:  2015-12-14

5.  The multidimensional construct of resilience across the psychosis spectrum: Evidence of alterations in people with early and prolonged psychosis.

Authors:  Lauren Luther; Cherise Rosen; John S Cummins; Rajiv P Sharma
Journal:  Psychiatr Rehabil J       Date:  2019-11-21

6.  The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study.

Authors:  Alessandro Rossi; Silvana Galderisi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Ileana Andriola; Antonello Bellomo; Massimo Biondi; Gaetano Callista; Anna Comparelli; Liliana Dell'Osso; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Cristiana Montemagni; Cinzia Niolu; Giuseppe Piegari; Federica Pinna; Rita Roncone; Paolo Stratta; Elena Tenconi; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-06       Impact factor: 5.270

7.  Defining Occupational Competence and Occupational Identity in the Context of Recovery in Schizophrenia.

Authors:  Bhing-Leet Tan; Madeline Wei Zhen Lim; Huiting Xie; Ziqiang Li; Jimmy Lee
Journal:  Am J Occup Ther       Date:  2020 Jul/Aug

8.  Factor structure and psychometric properties of the Connor-Davidson resilience scale (CD-RISC) in individuals with opioid use disorder.

Authors:  Suky Martinez; Jermaine D Jones; Laura Brandt; Denise Hien; Aimee N C Campbell; Sarai Batchelder; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2021-02-16       Impact factor: 4.492

9.  The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia.

Authors:  Michael Davidson
Journal:  Dialogues Clin Neurosci       Date:  2018-09       Impact factor: 5.986

10.  Resilience Predicts Self-Stigma and Stigma Resistance in Stabilized Patients With Bipolar I Disorder.

Authors:  Fabienne Post; Melanie Buchta; Georg Kemmler; Silvia Pardeller; Beatrice Frajo-Apor; Alex Hofer
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.